ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases

Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint Neuro Maestro Brain Model Comparative Reproducibility Error Results Reproducibility error of Maestro (green), FreeSurfer 7.2 (blue) and manual segmentation (red) for common brain structures (left), and average over all structures (right). Bars represent range of measured relative volume difference. SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NE
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint

Avatar Medical wins FDA clearance for VR surgical planning tech

FDA Approves Eflornithine to Reduce Risk of Relapse in High-Risk Neuroblastoma

SNN

Regulation Archives - NS Medical Devices

Michael Bigger on X: Day 1 $CLPT / X

ClearPoint Neuro, Inc. on LinkedIn: #quality #clearpoint #qualityengineer #employeehighlight #clpt

Our History

CLPT - ClearPoint Neuro Announces Pricing of Public Offering of

ClearPoint Neuro, Inc. Announces First-in-Human Cases of

CLPT - ClearPoint Neuro Announces Pricing of Public Offering of

Stock Market News 2024-02-21

SNN

ClearPoint Neuro Announces FDA Clearance for Software Version 2.1